Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
388,311,585
-
Total 13F shares
-
256,350,763
-
Share change
-
+9,281,102
-
Total reported value
-
$25,504,353,761
-
Put/Call ratio
-
72%
-
Price per share
-
$99.45
-
Number of holders
-
869
-
Value change
-
+$907,888,206
-
Number of buys
-
346
-
Number of sells
-
466
Institutional Holders of Moderna, Inc. - Common Stock (MRNA) as of Q4 2023
As of 31 Dec 2023,
Moderna, Inc. - Common Stock (MRNA) was held by
869 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
256,350,763 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Flagship Pioneering Inc., Theleme Partners LLP, WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, and GOLDMAN SACHS GROUP INC.
This page lists
870
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.